STAT3 and intrahepatic cholangiocarcinoma: Interestingly, we observed that the FISS-10-derived primary cells, which did not show immunoreactivity of phospho-STAT3 (Tyr705) in both IHC and ICC staining, were even more sensitive to LLL12 treatment than the FISS-14 primary cells.